Carnegie Investment Counsel’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.85M | Sell |
11,834
-25
| -0.2% | -$3.75K | 0.04% | 257 |
|
|
2026
Q1 | $1.81M | Sell |
11,859
-575
| -5% | -$88.1K | 0.04% | 266 |
|
|
2025
Q4 | $1.71M | Buy |
12,434
+200
| +2% | +$26.2K | 0.03% | 273 |
|
|
2025
Q3 | $1.57M | Sell |
12,234
-19
| -0.2% | -$2.32K | 0.03% | 273 |
|
|
2025
Q2 | $1.48M | Buy |
12,253
+584
| +5% | +$65.8K | 0.03% | 269 |
|
|
2025
Q1 | $1.2M | Hold |
11,669
| – | – | 0.03% | 267 |
|
|
2024
Q4 | $1.14M | Sell |
11,669
-200
| -2% | -$21.3K | 0.03% | 250 |
|
|
2024
Q3 | $1.37M | Buy |
11,869
+832
| +8% | +$94.4K | 0.04% | 241 |
|
|
2024
Q2 | $1.18M | Buy |
11,037
+2
| +0% | +$201 | 0.04% | 256 |
|
|
2024
Q1 | $1.07M | Sell |
11,035
-535
| -5% | -$54.9K | 0.03% | 282 |
|
|
2023
Q4 | $1.17M | Sell |
11,570
-52
| -0.4% | -$5.02K | 0.04% | 261 |
|
|
2023
Q3 | $1.18M | Sell |
11,622
-325
| -3% | -$33K | 0.05% | 252 |
|
|
2023
Q2 | $1.21M | Sell |
11,947
-28
| -0.2% | -$2.8K | 0.04% | 260 |
|
|
2023
Q1 | $1.1M | Sell |
11,975
-500
| -4% | -$43.7K | 0.04% | 276 |
|
|
2022
Q4 | $1.13M | Sell |
12,475
-46
| -0.4% | -$3.87K | 0.05% | 265 |
|
|
2022
Q3 | $952K | Buy |
12,521
+391
| +3% | +$32.4K | 0.05% | 268 |
|
|
2022
Q2 | $1.02M | Buy |
12,130
+235
| +2% | +$20.6K | 0.05% | 255 |
|
|
2022
Q1 | $1.04M | Sell |
11,895
-21
| -0.2% | -$1.82K | 0.04% | 264 |
|
|
2021
Q4 | $1.04M | Buy |
11,916
+800
| +7% | +$66.4K | 0.03% | 266 |
|
|
2021
Q3 | $909K | Hold |
11,116
| – | – | 0.03% | 257 |
|
|
2021
Q2 | $1.01M | Buy |
11,116
+252
| +2% | +$22.4K | 0.04% | 250 |
|
|
2021
Q1 | $929K | Sell |
10,864
-300
| -3% | -$26.9K | 0.04% | 250 |
|
|
2020
Q4 | $1.05M | Sell |
11,164
-705
| -6% | -$61.6K | 0.05% | 225 |
|
|
2020
Q3 | $1.03M | Sell |
11,869
-20
| -0.2% | -$1.73K | 0.05% | 212 |
|
|
2020
Q2 | $1.04M | Hold |
11,889
| – | – | 0.06% | 212 |
|
|
2020
Q1 | $979K | Sell |
11,889
-35
| -0.3% | -$3.12K | 0.07% | 199 |
|
|
2019
Q4 | $1.13M | Hold |
11,924
| – | – | 0.07% | 214 |
|
|
2019
Q3 | $1.04M | Sell |
11,924
-425
| -3% | -$38.2K | 0.07% | 215 |
|
|
2019
Q2 | $1.13M | Sell |
12,349
-1,675
| -12% | -$142K | 0.07% | 203 |
|
|
2019
Q1 | $1.21M | Sell |
14,024
-669
| -5% | -$53.7K | 0.08% | 198 |
|
|
2018
Q4 | $1.13M | Sell |
14,693
-2,016
| -12% | -$157K | 0.11% | 185 |
|
|
2018
Q3 | $1.31M | Buy |
16,709
+2,256
| +16% | +$167K | 0.11% | 178 |
|
|
2018
Q2 | $1.06M | Sell |
14,453
-668
| -4% | -$46.1K | 0.08% | 200 |
|
|
2018
Q1 | $1.05M | Sell |
15,121
-138
| -0.9% | -$10.5K | 0.09% | 190 |
|
|
2017
Q4 | $1.16M | Buy |
15,259
+2,890
| +23% | +$218K | 0.1% | 199 |
|
|
2017
Q3 | $952K | Sell |
12,369
-147
| -1% | -$11.1K | 0.11% | 184 |
|
|
2017
Q2 | $956K | Sell |
12,516
-112
| -0.9% | -$7.94K | 0.12% | 182 |
|
|
2017
Q1 | $892K | Sell |
12,628
-1,213
| -9% | -$80.8K | 0.11% | 181 |
|
|
2016
Q4 | $914K | Buy |
13,841
+112
| +0.8% | +$7.26K | 0.12% | 172 |
|
|
2016
Q3 | $930K | Sell |
13,729
-7,159
| -34% | -$522K | 0.13% | 161 |
|
|
2016
Q2 | $1.55M | Buy |
20,888
+474
| +2% | +$32.7K | 0.22% | 121 |
|
|
2016
Q1 | $1.32M | Buy |
20,414
+614
| +3% | +$41.8K | 0.2% | 127 |
|
|
2015
Q4 | $1.38M | Buy |
19,800
+1,829
| +10% | +$145K | 0.24% | 109 |
|
|
2015
Q3 | $1.45M | Buy |
17,971
+1,819
| +11% | +$162K | 0.25% | 99 |
|
|
2015
Q2 | $1.42M | Buy |
16,152
+3,210
| +25% | +$294K | 0.25% | 99 |
|
|
2015
Q1 | $1.2M | Buy |
12,942
+1,525
| +13% | +$135K | 0.21% | 114 |
|
|
2014
Q4 | $974K | Buy |
11,417
+335
| +3% | +$27.8K | 0.18% | 127 |
|
|
2014
Q3 | $935K | Sell |
11,082
-642
| -5% | -$51.9K | 0.19% | 129 |
|
|
2014
Q2 | $951K | Buy |
11,724
+151
| +1% | +$11.9K | 0.22% | 107 |
|
|
2014
Q1 | $882K | Hold |
11,573
| – | – | 0.23% | 99 |
|
|
2013
Q4 | $834K | Sell |
11,573
-89
| -0.8% | -$6.19K | 0.22% | 105 |
|
|
2013
Q3 | $802K | Buy |
11,662
+530
| +5% | +$35.1K | 0.25% | 99 |
|
|
2013
Q2 | $705K | Buy |
+11,132
| New | +$724K | 0.23% | 105 |
|
Other funds holding NVS
TAM
SI
Carnegie Investment Counsel's NVS Position: Q2 2026 in Review
Carnegie Investment Counsel reduced its Novartis (NVS) stake by 0.21% in Q2 2026, selling an estimated $3.75K and leaving 11,834 shares worth $1.85M. The position accounts for 0.04% of the portfolio, ranked #257.
Carnegie Investment Counsel first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Carnegie Investment Counsel held 11,834 shares of Novartis worth $1.85M as of Q2 2026.
- Carnegie Investment Counsel sold 25 Novartis shares in Q2 2026, an estimated $3.75K.
- Novartis made up 0.04% of Carnegie Investment Counsel's portfolio in Q2 2026, its #257 holding.
- Carnegie Investment Counsel first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.